SHE:002821 Market Cap

SHE:002821 has a market cap or net worth of 35.19 billion as of January 27, 2026. Its market cap has increased by 32.72% in one year.

Market Cap

35.19B

Enterprise Value

27.63B

Revenue

6.29B

Ranking

n/a

PE Ratio

34.94

Stock Price

99.98

Market Cap Chart

Since November 18, 2016, SHE:002821's market cap has increased from 4.96B to 35.19B, an increase of 609.21%. That is a compound annual growth rate of 23.75%.

Market Cap History

Date	Market Cap	% Change
Jan 26, 2026	35.68B	9.44%
Dec 31, 2025	32.61B	24.27%
Dec 31, 2024	26.24B	-36.60%
Dec 29, 2023	41.39B	-21.47%
Dec 30, 2022	52.70B	-52.62%
Dec 31, 2021	111.23B	53.32%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Nov 18, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Pharmaron Beijing	52.08B
Hebei Changshan Biochemical Pharmaceutical	50.57B
Shanghai Allist Pharmaceuticals	44.90B
Chongqing Zhifei Biological Products	44.62B
Shanghai RAAS Blood Products	43.13B
Sunshine Guojian Pharmaceutical (Shanghai)	39.27B
Beijing Tiantan Biological Products	34.45B
Xiamen Amoytop Biotech	31.02B

Market Cap Rankings